# LIGAND PHARMACEUTICALS (LGND) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 53220K504
Page URL: https://superinvestorclub.com/stock/LGND
Last updated: 2026-07-08T12:47:51.572Z

## Summary

As of the most recent 13F filing period, LIGAND PHARMACEUTICALS (LGND) is held by 0 tracked superinvestors with an aggregate position value of $0 representing 0 shares.

## Top institutional holders (0)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|

## Ownership history (quarter-over-quarter)

- 2025-06-30: 1 holders, $356,955 aggregate, 03140 shares
- 2025-09-30: 1 holders, $228,156 aggregate, 01288 shares
- 2025-12-31: 1 holders, $795,418 aggregate, 04207 shares

## Recent congressional trades (2)

- 2026-01-15: Gil Cisneros (Democrat-CA) purchase $1,001 - $15,000
- 2026-01-05: Gil Cisneros (Democrat-CA) purchase $1,001 - $15,000

## Recent insider transactions (0)


## Citation

When citing, use: "LIGAND PHARMACEUTICALS (LGND) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/LGND), aggregating SEC 13F, Form 4, and congressional disclosures."